LPIR is a non-insulin dependent fasting test that quantifies one of the earliest manifestations of insulin resistance—dyslipidemia characterized by elevations in triglyceride and lower high-density lipoprotein cholesterol concentrations. The gene discussed is INS; the disease is metabolic syndrome.